Compare TMCI & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TMCI | MRCC |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.0M | 135.8M |
| IPO Year | 2021 | 2012 |
| Metric | TMCI | MRCC |
|---|---|---|
| Price | $1.84 | $6.16 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $4.21 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 617.2K | 102.8K |
| Earning Date | 02-27-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 11.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,879,000.00 | $43,742,000.00 |
| Revenue This Year | $3.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.90 | N/A |
| 52 Week Low | $1.86 | $5.86 |
| 52 Week High | $10.30 | $8.85 |
| Indicator | TMCI | MRCC |
|---|---|---|
| Relative Strength Index (RSI) | 28.79 | 39.84 |
| Support Level | $2.02 | $5.96 |
| Resistance Level | $2.31 | $6.40 |
| Average True Range (ATR) | 0.16 | 0.18 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 7.88 | 26.76 |
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.